Anemia Industry, March 2015 Market Reports from Top Publishers

You might be interested in: nucleic acid testing, therapeutics, chemotherapy, drug delivery, injectable drug delivery, medical equipment, biosimilar, coagulation.


 
1-10 of 51 reports for Anemia

Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs ...

Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the ...

Iron Deficiency Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Iron Deficiency Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Iron Deficiency Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

Aplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Aplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Aplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

Congenital Hypoplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Congenital Hypoplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Congenital Hypoplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

Megaloblastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Megaloblastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Megaloblastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

Pernicious Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Pernicious Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Pernicious Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

Refractory Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Refractory Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Refractory Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

Renal Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Renal Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Renal Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

Pathology in United States: Iron Deficiency Anemia – Pipeline Review, H1 2012

Pathology in United States: Iron Deficiency Anemia – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

This report provides data on the therapeutic development for Iron Deficiency Anemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

About 2 000 reports for Anemia

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Ethiopia

  • January 2014
    7 pages
  • Anemia  

  • Ethiopia  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.